Jaime Contreras, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 400 shares at $37.87 ($15K) on 2016-02-16, disclosed to the SEC on 2016-02-17.
Scheduled sale ($15k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.13 | 146 | $5K | 36.0% |
| 2 | $37.87 | 254 | $10K | 64.0% |
| Total | $37.60 avg | 400 | $15K | 100% |
| Filing → |
| ABT | SELL | 2019-04-24 | $134K | — | Filing → |
| ABT | SELL | 2019-03-04 | $1.9M | — | Filing → |
| ABT | SELL | 2019-02-01 | $12.4M | — | Filing → |